Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers’ workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Market Valuation | Analyst price targets range from $19 to $28, reflecting Privia's premium valuation justified by its durable business model and growth potential |
Growth Dynamics | Delve into Privia's provider network expansion strategy, balancing short-term fluctuations with long-term implementation pipelines |
Financial Trajectory | Explore Privia's solid Q1 performance, with care margin and EBITDA exceeding expectations, and analyst projections of EPS growth for coming years |
Strategic Resilience | Privia Health's balanced approach in ACO management and risk mitigation showcases its adaptability in a complex healthcare landscape |
Metrics to compare | PRVA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPRVAPeersSector | |
---|---|---|---|---|
P/E Ratio | 204.4x | −19.6x | −0.7x | |
PEG Ratio | −3.26 | −0.08 | 0.00 | |
Price / Book | 4.3x | 1.3x | 2.6x | |
Price / LTM Sales | 1.5x | 0.9x | 3.2x | |
Upside (Analyst Target) | 15.1% | 30.5% | 47.0% | |
Fair Value Upside | Unlock | 12.2% | 8.3% | Unlock |